Literature DB >> 1700056

Enhancement of human basophil histamine release by interleukin 5.

K Hirai1, M Yamaguchi, Y Misaki, T Takaishi, K Ohta, Y Morita, K Ito, T Miyamoto.   

Abstract

Substantial evidence indicates a close relationship between eosinophils and basophils. We examined whether interleukin 5 (IL-5), known to be eosinophilopoietic and capable of selectively regulating eosinophil functions, has an affect on basophil functions. IL-5 enhanced basophil histamine release evoked by anti-IgE, formyl-methionyl-leucyl-phenylalanine, or ionophore A23187 at picomolar concentrations. Direct action of IL-5 on human basophils was confirmed using highly purified basophil populations. These observations reveal the novel fact that IL-5 is able to modulate basophil functions as well as eosinophil functions, and suggest that normal human basophils possess functional receptors for IL-5.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1700056      PMCID: PMC2188680          DOI: 10.1084/jem.172.5.1525

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  15 in total

1.  Modulation of human basophil histamine release by hemopoietic growth factors.

Authors:  K Hirai; Y Morita; Y Misaki; K Ohta; T Takaishi; S Suzuki; K Motoyoshi; T Miyamoto
Journal:  J Immunol       Date:  1988-12-01       Impact factor: 5.422

2.  Selective differentiation and proliferation of hematopoietic cells induced by recombinant human interleukins.

Authors:  H Saito; K Hatake; A M Dvorak; K M Leiferman; A D Donnenberg; N Arai; K Ishizaka; T Ishizaka
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

3.  Cloning of cDNA for human T-cell replacing factor (interleukin-5) and comparison with the murine homologue.

Authors:  C Azuma; T Tanabe; M Konishi; T Kinashi; T Noma; F Matsuda; Y Yaoita; K Takatsu; L Hammarström; C I Smith
Journal:  Nucleic Acids Res       Date:  1986-11-25       Impact factor: 16.971

Review 4.  T cell-replacing factor (TRF)/interleukin 5 (IL-5): molecular and functional properties.

Authors:  K Takatsu; A Tominaga; N Harada; S Mita; M Matsumoto; T Takahashi; Y Kikuchi; N Yamaguchi
Journal:  Immunol Rev       Date:  1988-02       Impact factor: 12.988

5.  A hybrid eosinophilic-basophilic granulocyte in chronic granulocytic leukemia.

Authors:  S C Weil; M A Hrisinko
Journal:  Am J Clin Pathol       Date:  1987-01       Impact factor: 2.493

6.  The neutrophil-activating peptide NAF/NAP-1 induces histamine and leukotriene release by interleukin 3-primed basophils.

Authors:  C A Dahinden; Y Kurimoto; A L De Weck; I Lindley; B Dewald; M Baggiolini
Journal:  J Exp Med       Date:  1989-11-01       Impact factor: 14.307

7.  Recombinant human interleukin 5 is a selective activator of human eosinophil function.

Authors:  A F Lopez; C J Sanderson; J R Gamble; H D Campbell; I G Young; M A Vadas
Journal:  J Exp Med       Date:  1988-01-01       Impact factor: 14.307

8.  Formation of Charcot-Leyden crystals by human basophils.

Authors:  S J Ackerman; G J Weil; G J Gleich
Journal:  J Exp Med       Date:  1982-06-01       Impact factor: 14.307

9.  Highly purified murine interleukin 5 (IL-5) stimulates eosinophil function and prolongs in vitro survival. IL-5 as an eosinophil chemotactic factor.

Authors:  Y Yamaguchi; Y Hayashi; Y Sugama; Y Miura; T Kasahara; S Kitamura; M Torisu; S Mita; A Tominaga; K Takatsu
Journal:  J Exp Med       Date:  1988-05-01       Impact factor: 14.307

10.  Murine eosinophil differentiation factor. An eosinophil-specific colony-stimulating factor with activity for human cells.

Authors:  A F Lopez; C G Begley; D J Williamson; D J Warren; M A Vadas; C J Sanderson
Journal:  J Exp Med       Date:  1986-05-01       Impact factor: 14.307

View more
  11 in total

Review 1.  Pharmacokinetics and pharmacodynamics of mepolizumab, an anti-interleukin-5 monoclonal antibody.

Authors:  Deborah A Smith; Elisabeth A Minthorn; Misba Beerahee
Journal:  Clin Pharmacokinet       Date:  2011-04       Impact factor: 6.447

2.  Engineering of a functional interleukin-5 monomer: a paradigm for redesigning helical bundle cytokines with therapeutic potential in allergy and asthma.

Authors:  R R Dickason; J D English; D P Huston
Journal:  J Mol Med (Berl)       Date:  1996-09       Impact factor: 4.599

3.  Differential response of human basophils and mast cells to recombinant chemokines.

Authors:  W Füreder; H Agis; H Semper; F Keil; U Maier; M R Müller; K Czerwenka; H Höfler; K Lechner; P Valent
Journal:  Ann Hematol       Date:  1995-05       Impact factor: 3.673

4.  Mapping of the interleukin 5 receptor gene to human chromosome 3 p25-p26 and to mouse chromosome 6 close to the Raf-1 locus with polymorphic tandem repeat sequences.

Authors:  C O Jacob; K Mykytyn; T Varcony; H A Drabkin
Journal:  Mamm Genome       Date:  1993       Impact factor: 2.957

5.  Characterization of histamine-releasing activity: role of cytokines and IgE heterogeneity.

Authors:  T N Liao; K H Hsieh
Journal:  J Clin Immunol       Date:  1992-07       Impact factor: 8.317

Review 6.  Th2 cytokines and asthma. The role of interleukin-5 in allergic eosinophilic disease.

Authors:  S Greenfeder; S P Umland; F M Cuss; R W Chapman; R W Egan
Journal:  Respir Res       Date:  2001-03-08

Review 7.  Pathogenesis of eosinophilic chronic rhinosinusitis.

Authors:  Said Ahmad Shah; Hajime Ishinaga; Kazuhiko Takeuchi
Journal:  J Inflamm (Lond)       Date:  2016-04-06       Impact factor: 4.981

Review 8.  Mepolizumab in the management of severe eosinophilic asthma in adults: current evidence and practical experience.

Authors:  Gilda Varricchi; Diego Bagnasco; Matteo Ferrando; Francesca Puggioni; Giovanni Passalacqua; Giorgio W Canonica
Journal:  Ther Adv Respir Dis       Date:  2016-11-17       Impact factor: 4.031

9.  Identification of the second subunit of the murine interleukin-5 receptor: interleukin-3 receptor-like protein, AIC2B is a component of the high affinity interleukin-5 receptor.

Authors:  S Takaki; S Mita; T Kitamura; S Yonehara; N Yamaguchi; A Tominaga; A Miyajima; K Takatsu
Journal:  EMBO J       Date:  1991-10       Impact factor: 11.598

10.  Interleukin-5 potentiates sulfidopeptide leukotriene production by human eosinophils.

Authors:  A J Van Oosterhout; A Van Der Poel; L Koenderman; D Roos; F P Nijkamp
Journal:  Mediators Inflamm       Date:  1994       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.